Publishing high quality, peer reviewed original research and reviews addressing all aspects of basic biology and clinical use of haemopoietic cell transplantation. Official journal of the EBMT.
New Editor-in-Chief: Professor Bipin N. Savani
On 1 May 2022, we welcome Prof. Bipin N. Savani as the new co-Editor-in-Chief of Bone Marrow Transplantation, working alongside Prof. Mohamad Mohty. Prof. Savani, based at Vanderbilt University Medical Center, USA, succeeds Prof. Hillard Lazarus. We would like to express our thanks to Prof. Lazarus for the dedication and drive he has shown during his time working on the journal in this role.
Trending - Altmetric
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study
Diversity, equity, and inclusion in transfusion medicine, blood donation, and blood and bone marrow transplantation: language matters